LABCORP HOLDINGS INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
LABCORP HOLDINGS INC. (LH) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of $232.60 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-02-24
- LABCORP HOLDINGS INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was $232.60M, a 15.43% increase from fiscal 2024.
- LABCORP HOLDINGS INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was $201.50M, a 68.62% increase from fiscal 2023.
- LABCORP HOLDINGS INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was $119.50M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month |
|---|---|
| 2025-12-31 | $232.60M 10-K · filed 2026-02-24 |
| 2024-12-31 | $201.50M 10-K · filed 2026-02-24 |
| 2023-12-31 | $119.50M 10-K · filed 2026-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |